• Share article :

3D bioprinting utilizes a layer by layer method to precisely dispense cell-laden for the construction of complex 3D functional tissue-like structures or artificial organs. While it is still in the early stages, bioprinting strategies have demonstrated their potential use in regenerative medicine to generate a variety of transplantable tissues, including skin, blood vessels, and bone.

The NUS Centre for Additive Manufacturing (AM.NUS) is part of multi-disciplinary initiatives to accelerate the adoption of 3D printing technology in Singapore. With a focus on 3D printing applications in Healthcare, we seek to improve patient outcomes through innovative 3D printed products and processes.

CELLINK focuses on the development and commercialization of bioprinting technologies that allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products, and in the future, for clinical applications. CELLINK’s innovative and patent pending bioink is a biomaterial innovation that enables human cells to grow and thrive such as they would in the natural human body environment. Today, the company’s disruptive tech platform is being utilized to print tissues such as liver, skin, cartilage, and even fully functional cancer tumors that can then be used to develop new cancer treatments.

Therefore we invite university colleagues and clinicians to join the workshop and networking event to discuss and learn more about bioprinting’s unique advantages, opportunities, and challenges.